SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882095-24-000016
Filing Date
2024-05-09
Accepted
2024-05-09 16:11:00
Documents
15
Period of Report
2024-05-08
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gild-20240508.htm   iXBRL 8-K 71601
2 2024 RESTATED CERTIFICATE OF INCORPORATION ex312024certificateofamend.htm EX-3.1 9965
3 2024 CERTIFICATE OF AMENDMENT OF RESTATED CERTIFICATE OF INCORPORATION ex322024restatedcertificat.htm EX-3.2 50860
  Complete submission text file 0000882095-24-000016.txt   278004

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gild-20240508.xsd EX-101.SCH 1914
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gild-20240508_lab.xml EX-101.LAB 22788
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gild-20240508_pre.xml EX-101.PRE 13056
18 EXTRACTED XBRL INSTANCE DOCUMENT gild-20240508_htm.xml XML 3009
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 24930688
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)